MTEX Fundamental Analysis - MANNATECH INC

Fundamental Rating

Overall MTEX gets a fundamental rating of 2 out of 10. We evaluated MTEX against 36 industry peers in the Personal Care Products industry. MTEX may be in some trouble as it scores bad on both profitability and health. MTEX has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MTEX has reported negative net income.

MTEX had a negative operating cash flow in the past year.

In multiple years MTEX reported negative net income over the last 5 years.

In multiple years MTEX reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of MTEX (-11.92%) is worse than 72.22% of its industry peers.

Looking at the Return On Equity, with a value of -65.53%, MTEX is doing worse than 69.44% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-11.92%
ROE	-65.53%
ROIC	N/A

ROA(3y)-2.56%

ROA(5y)3.68%

ROE(3y)-8.05%

ROE(5y)8.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of MTEX has remained more or less at the same level.

MTEX's Operating Margin has declined in the last couple of years.

MTEX's Gross Margin of 75.79% is amongst the best of the industry. MTEX outperforms 86.11% of its industry peers.

In the last couple of years the Gross Margin of MTEX has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for MTEX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	75.79%

OM growth 3Y-40.07%

OM growth 5Y-21.47%

PM growth 3Y-29.9%

PM growth 5Y0.19%

GM growth 3Y-0.43%

GM growth 5Y-0.61%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MTEX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, MTEX has more shares outstanding

MTEX has less shares outstanding than it did 5 years ago.

MTEX has a worse debt/assets ratio than last year.

2.2 Solvency

MTEX has an Altman-Z score of 3.64. This indicates that MTEX is financially healthy and has little risk of bankruptcy at the moment.

MTEX has a Altman-Z score of 3.64. This is comparable to the rest of the industry: MTEX outperforms 58.33% of its industry peers.

A Debt/Equity ratio of 0.58 indicates that MTEX is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.58, MTEX is doing worse than 61.11% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.58
Debt/FCF	N/A
Altman-Z	3.64

ROIC/WACCN/A

WACC9.2%

2.3 Liquidity

A Current Ratio of 1.11 indicates that MTEX should not have too much problems paying its short term obligations.

With a Current ratio value of 1.11, MTEX is not doing good in the industry: 69.44% of the companies in the same industry are doing better.

A Quick Ratio of 0.49 indicates that MTEX may have some problems paying its short term obligations.

MTEX's Quick ratio of 0.49 is on the low side compared to the rest of the industry. MTEX is outperformed by 86.11% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.11
Quick Ratio	0.49

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MTEX have decreased strongly by -220.46% in the last year.

The Earnings Per Share has been decreasing by -0.73% on average over the past years.

Looking at the last year, MTEX shows a decrease in Revenue. The Revenue has decreased by -7.72% in the last year.

MTEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.66% yearly.

EPS 1Y (TTM)-220.46%

EPS 3Y-34.31%

EPS 5Y-0.73%

EPS Q2Q%-585.29%

Revenue 1Y (TTM)-7.72%

Revenue growth 3Y-9.65%

Revenue growth 5Y-5.66%

Sales Q2Q%-7.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MTEX. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MTEX is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	18.71

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MTEX has a Yearly Dividend Yield of 8.83%, which is a nice return.

MTEX's Dividend Yield is rather good when compared to the industry average which is at 5.62. MTEX pays more dividend than 94.44% of the companies in the same industry.

MTEX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.

		Industry Rank	Sector Rank
Dividend Yield	8.83%

5.2 History

MTEX has been paying a dividend for at least 10 years, so it has a reliable track record.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DP0%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MANNATECH INC

NASDAQ:MTEX (9/23/2025, 8:00:01 PM)

8.6

+0.04 (+0.47%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)08-12 2025-08-12

Earnings (Next)11-10 2025-11-10

Inst Owners18.93%

Inst Owner Change0.14%

Ins Owners44.9%

Ins Owner Change0%

Market Cap16.34M

Analysts0

Price TargetN/A

Short Float %1.11%

Short Ratio0.47

Dividend

		Industry Rank	Sector Rank
Dividend Yield	8.83%

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.14
P/FCF	N/A
P/OCF	N/A
P/B	2.74
P/tB	2.74
EV/EBITDA	18.71

EPS(TTM)-2.05

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-1.48

FCFYN/A

OCF(TTM)-1.07

OCFYN/A

SpS59.46

BVpS3.14

TBVpS3.14

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-11.92%
ROE	-65.53%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	75.79%
FCFM	N/A

ROA(3y)-2.56%

ROA(5y)3.68%

ROE(3y)-8.05%

ROE(5y)8.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-40.07%

OM growth 5Y-21.47%

PM growth 3Y-29.9%

PM growth 5Y0.19%

GM growth 3Y-0.43%

GM growth 5Y-0.61%

F-Score3

Asset Turnover3.45

Health

		Industry Rank	Sector Rank
Debt/Equity	0.58
Debt/FCF	N/A
Debt/EBITDA	4.42
Cap/Depr	60.29%
Cap/Sales	0.69%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.11
Quick Ratio	0.49
Altman-Z	3.64

F-Score3

WACC9.2%

ROIC/WACCN/A

Cap/Depr(3y)43.45%

Cap/Depr(5y)43.17%

Cap/Sales(3y)0.53%

Cap/Sales(5y)0.53%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-220.46%

EPS 3Y-34.31%

EPS 5Y-0.73%

EPS Q2Q%-585.29%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-7.72%

Revenue growth 3Y-9.65%

Revenue growth 5Y-5.66%

Sales Q2Q%-7.43%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y48.43%

EBIT growth 3Y-45.85%

EBIT growth 5Y-25.91%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y55.13%

FCF growth 3Y-42.1%

FCF growth 5Y-11.9%

OCF growth 1Y62.42%

OCF growth 3Y-40.57%

OCF growth 5Y-14.4%

MANNATECH INC (MTEX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens